Cell Processing at CAGT. Overview. Adrian P. Gee Center for Cell & Gene Therapy. CAGT Introduction
|
|
- Logan Young
- 6 years ago
- Views:
Transcription
1 Cell Processing at CAGT Adrian P. Center for Cell & Gene Therapy CAGT Introduction Overview Facility Description Products prepared Flow cytometry Quality Control Quality Assurance 1
2 Center for Cell & Gene Therapy CAGT Component Parts Basic & Translational Research Clinical Treatment & Research 2
3 Feigin Center at TCH 15 th Floor Protocol & Regulatory Affairs 16 th Floor Offices and GMP facilities Primary Location 17 th Floor Translational Research Translational Research 17 th Floor Performs Pre GMP research and translation Performs Pre GMP research and translation ~ 80 staff, graduate students, post docs and PIs Excellent source of new GMP projects 3
4 GMP Facilities GMP History There has been a GMP facility at BCM since 1992 vector manufacturing Expanded on arrival of CAGT in 1998 Construction of GMP Cell Processing Subsequent reconstruction o of Vector Facility Moved to 16 th floor in
5 Construction 16 th Floor Feigin Center 5
6 Cell Processing Main Vector Production Facility 6
7 Special Processing Receiving & Storage 7
8 Cell Banks Quality Assurance & Control 8
9 Offices & Administration HVAC Systems Cell Processing Facility 60 air changes per hour Recirculated air 9
10 CPF Flowpath Cell Processing Facility Single corridor design HVAC Systems Vector Production Facility 60 air changes per hour 100% exhausted air 10
11 VPF Flowpath Vector Production Facility Clean & dirty corridors Quality Control Cell Processing Released Supplies Quality Assurance Quality Control Cell Storage Gowning Freezer Storage Flow Flow Cytometry Gowning Vector Production Materials Management Traffic Pattern Cell Processing Supplies Administration Pass through Offices & Administration QA Materials Management Supplies Gowning Swing Suites Vector Production QA 11
12 Range of Cell & Gene Therapy Products HPC Dendritic Cells Cytotoxic T Cells Natural Killer Cells Mesenchymal Stromal Cells Lymphoblastoid Cells Monocytes Viral Vectors Leukemia Cell Vaccines Products Manufactured Products Manufactured Hematopoietic Progenitor Cells (HPC) HPC, Marrow, Unmanipulated HPC, Marrow, Red cell-depleted HPC, Marrow, Plasma depleted HPC, Marrow, CD34 selected HPC, Apheresis, Plasma-depleted Marrow mononuclear cells (MNC) cardiac repair Marrow CD34-selected cardiac repair Marrow MNC traumatic brain injury Marrow MNC stroke patients HPC - Cord blood AC133-selected, ex vivo expanded For hearing loss & brain injury Lymphoblastoid cell lines +/- genetic modification Intermediate product Donor leukocytes (DLI) Hepatic progenitor cells Pancreatic islet cells allogeneic GMP-grade EBV NK Cells Products Manufactured Cytotoxic T cells (CTLS) CTLs EBV directed CTLs LMP2 directed CTLs LMP1/LMP2-directed CTLs Adenovirus directed CTLs tri-virus directed CTL EBV/Neuroblastoma directed CTL- Genetically modified (TGFβ etc) Genetically-modified allodepleted donor T lymphocytes Tumor vaccines +/- genetic modification TV autologous neuroblastoma-directed TV- allogeneic neuroblastoma-directed TV- autologous CLL-directed Mesenchymal stem/progenitor cells (MSC) Antigen presenting cells (APC) APC dendritic cells Intermediate product APC monocytes intermediate product APC gene modified leukemic cell lines 12
13 Flow Cytometry 4.5 Staff CAP accredited d 2BD Canto II & 1 Canto 6Lyse Wash Assistants Product analysis Mobilization Immune reconstitution Quality Control 7Staff Perform or send out all product testing Endosafe Mycoplasma Bioburden Viral titers EBV (for TCH) Recombinant virus detection Environmental monitoring 13
14 Quality Assurance 3 staff (1 TBA) Review production records Review equipment & environmental records Control documentation Training Proficiency i Competency Master Files Etc.etc. Audits GMP External Customers 14
15 Come & see the real thing! Tours available both afternoons 15
Challenges associated with supply to larger patients populations: Elements of the CTL019 experience
Cell and Gene Therapy Challenges associated with supply to larger patients populations: Elements of the CTL019 experience Daniel Stark Head External Supply Cell- and Gene Therapies Development and Manufacturing
More informationHematopoietic Stem Cells: Cell Processing, and Transplantation
Hematopoietic Stem Cells: Cell Processing, and Transplantation Rona Singer Weinberg, PhD Director, Cellular Therapy Laboratory New York Blood Center Phone: (212) 570-3488 E-mail: rweinberg@nybloodcenter.org
More informationINTERNATIONAL STANDARDS FOR HEMATOPOIETIC CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION
INTERNATIONAL STANDARDS FOR HEMATOPOIETIC CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION Seventh Edition DRAFT May 2017 NOTICE These Standards are designed to provide minimum guidelines
More informationSTANDARDS FOR IMMUNE EFFECTOR CELLS
STANDARDS FOR IMMUNE EFFECTOR CELLS January 2017 NOTICE These Standards are designed to provide minimum guidelines for programs, facilities, and individuals performing cellular therapy or providing support
More informationINTERNATIONAL STANDARDS FOR HEMATOPOIETIC CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION
INTERNATIONAL STANDARDS FOR HEMATOPOIETIC CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION Sixth Edition Version 6.1 NOTICE These Standards are designed to provide minimum guidelines
More informationPACT. PACT Program. Production Assistance for Cellular Therapies
PACT Production Assistance for Cellular Therapies University of Wisconsin PACT-sponsored Workshop Developing Cellular Therapies: From Preclinical Safety To Clinical Evaluation Tuesday, April 09, 2013 Robert
More informationINTERNATIONAL STANDARDS FOR CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION FOR HEMATOPOIETIC CELLULAR THERAPIES
INTERNATIONAL STANDARDS FOR CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION FOR HEMATOPOIETIC CELLULAR THERAPIES Draft Sixth Edition April 2014 NOTICE These Standards are designed to
More informationCase Study: Examples Relating to the Quality Control of Cell-based Products
Case Study: Examples Relating to the Quality Control of Cell-based Products CMC Strategy Forum Japan 2014 Yuuki Miyatake1), 2) 1) TEIJIN PHARMA LIMITED 2) Japan Pharmaceutical Manufacturers Association
More informationClinical and Operational Infrastructure for Engineered Cell Therapy Delivery
Clinical and Operational Infrastructure for Engineered Cell Therapy Delivery Sarah Nikiforow, MD, PhD Dana-Farber Cancer Institute Clinical Instructor, Stem Cell Transplantation Assistant Medical Director
More informationAntibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies
Human AB Serum Product Description Human AB Serum is a vital cell culture reagent for some human cell types providing growth factors, vitamins, nutrients as well as trace elements and transport factors,
More informationRegulatory Pathways for Rare Diseases
Regulatory Pathways for Rare Diseases Celia M. Witten, Ph.D., M.D. Deputy Director, FDA Center for Biologics Evaluation and Research Emerging Technologies for Rare Diseases: Clinical and Regulatory Case
More informationProduction Assistance for Cellular Therapies PACT
Production Assistance for Cellular Therapies PACT Traci Heath Mondoro, PhD NHLBI Bethesda, Maryland Renewed PACT Program Renewed January 15, 2010 Scope and size expanded Cell Processing Facilities (CPFs)
More informationFDA Oversight of Gene Therapy
FDA Oversight of Gene Therapy Celia M. Witten, Ph.D., M.D. Deputy Director, FDA CBER Rare Disease and Orphan Products Breakthrough Summit NORD October 17, 2016 Hyatt Regency Crystal City Crystal City,
More informationPROTOCOL FOR A RESEARCH SAMPLE REPOSITORY FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, OTHER CELLULAR THERAPIES AND MARROW TOXIC INJURIES
Center for International Blood and Marrow Transplant Research PROTOCOL FOR A RESEARCH SAMPLE REPOSITORY FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, OTHER CELLULAR THERAPIES AND MARROW TOXIC
More informationAdvanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None
EAHP March 2016 Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4 Dr. Lenka Taylor Pharmacy University Hospital Heidelberg Disclosure Relevant Financial Relationships
More informationDes cellules-souches dans le poumon : pourquoi faire?
Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland
More informationAlphabetical Glossary of Terms. Gene Therapy & Immunotherapy for Cancer
Alphabetical Glossary of Terms Gene Therapy & Immunotherapy for Cancer Introduction The purpose of this glossary is to provide clarification of the most commonly used terms related to cancer research and
More information4000: Cellular Therapy Essential Data Pre- Infusion
4000: Cellular Therapy Essential Data Pre- Infusion! This form must be completed for all recipients of cellular therapy (non-hct) where it is the first indication for treatment (no prior hematopoietic
More informationThe promise of T cell engineering CD19 CAR therapy A prologue to immune regenerative medicine Vast potential, patience, public education
The promise of T cell engineering CD19 CAR therapy A prologue to immune regenerative medicine Vast potential, patience, public education Academies Cell Therapy Workshop Washington, October 13, 2016 Michel
More informationAt the conclusion of this lesson you should be able to:
Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate
More informationCAP Accreditation Checklists 2017 Edition
CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
More informationWhat Are Stem Cells? Where Are These Stem Cells?
While stem cell therapies may seem to have appeared overnight, they have been practiced for some time prior to the recent burst in new applications and stem cell sources. The most recent developments in
More informationManufacturing Challenges with Cell and Gene Therapy Products: A Health Canada Perspective
Manufacturing Challenges with Cell and Gene Therapy Products: A Health Canada Perspective CASSS CMC Summer Forum 2017 Chris Storbeck, PhD Health Canada Outline Health Canada organization Regulation of
More informationClinical Applications of Mesenchymal Stromal Cells
Clinical Applications of Mesenchymal Stromal Cells John Girdlestone PhD Stem Cells and Immunotherapies NHS Blood and Transplant, Oxford John Radcliffe Hospital Mesenchymal Stromal Cells (MSC) Fibroblastic,
More informationCell Therapy Services Your Product. Our Passion.
Pharma&Biotech Cell Therapy Services Your Product. Our Passion. Complete Portfolio of Services for cgmp Manufacturing of Cell-based Products Pharma&Biotech Cell Therapy Services for cgmp Manufacturing
More informationStrategies for Assessment of Immunotoxicology in Preclinical Drug Development
Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects
More informationCHANGES TO A GENE THERAPY MEDICINAL PRODUCT: REGULATORY VIEWS
CHANGES TO A GENE THERAPY MEDICINAL PRODUCT: REGULATORY VIEWS Maria Cristina Galli, Ph.D. Istituto Superiore di Sanità Roma, Italy EATRIS ATMP platform chair ISCT 2016 Global Regulatory Perspective Workshop
More informationExhibit Floorplan update Grand Ballroom ABCD
Exhibit Floorplan update Grand Ballroom ABCD 100 102 104 106 Booth # Company/Organization 100 Lonza Walkersville, Inc. 101 Compass Biomedical 102 stemtrak 101 105 109 104 Biosafe America, Inc. 105 Waisman
More informationStem Cell Services. Driving Innovation for Stem Cell Researchers
Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,
More informationLong-Term Follow-Up in Gene Transfer Clinical Research
Long-Term Follow-Up in Gene Transfer Clinical Research Jan P. Vleck, MD CIP Institutional Biosafety Committee Services A Division of WIRB www.ibcservicepoint.com ibcs@wirb.com What is LTFU? the collection
More informationISBT 128 coding system and the Single European Code: Introduction. Presented by: Jessy Lardon
ISBT 128 coding system and the Single European Code: Introduction Presented by: Jessy Lardon Single European Code (= SEC) The SEC is the unique identifier applied to tissues and cells distributed in the
More informationHSC enumeration of fresh samples
HSC enumeration of fresh samples Claude LEMARIÉ QC Facility Medical Director Cell Therapy Facility, Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Comprehensive
More informationUpdate from the Center for Biologics Evaluation and Research (CBER): Advancing the Development of Complex Biologic Products
Update from the Center for Biologics Evaluation and Research (CBER): Advancing the Development of Complex Biologic Products Peter Marks, M.D., Ph.D. FDLI 2017 Outline Products regulated Significance of
More informationDevelopment of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach
3 July 2017 EMA/CAT/216556/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the
More informationProcess Robustness & Challenges to Demonstrating Compliance
Process Robustness & Challenges to Demonstrating Compliance Nick Smith Head of Production & TSS 2 nd March 2017 95% Thomas Eldered 5% Management Headcount : 270 3 GMP facilities Cobra s Structure Cobra
More informationMeasurement of Hematopoietic Stem Cell Potency Prior to Transplantation
WHITE PAPER Measurement of Hematopoietic Stem Cell Potency Prior to Transplantation February, 2009 This White Paper is a forward-looking statement. It represents the present state of the art and future
More informationHematopoietic Stem Cells
Hematopoietic Stem Cells ISOLATE & CULTURE VERIFY DIFFERENTIATE INVESTIGATE ISOLATE AND CULTURE Mouse Hematopoietic Cell Lineage Depletion Kit ( MAGM29) Both positive and negative selection methods can
More informationImmunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications
Immunogenicity of Stem Cells in Therapeutic Applications MDPB-Registry meeting nov 25th 2016 Stem cell immunogenicity in therapeutic applications Has it been underestimated? Transplantation of any type
More informationHSV-2 therapeutic vaccine program. Subunit vaccine candidates
HSV-2 therapeutic vaccine program Subunit vaccine candidates Our HSV-2 vaccine program Therapeutic subunit vaccine T-cell-based Aim: Best-in-class antigens by engineering Excellent standing (Sept 2017):
More informationHematopoietic stem. Hematopoietic Stem and Progenitor Cells. Congenital immune deficiencies severe combined immunodeficiency
23 Hematopoietic Stem and Progenitor Cells Hematopoietic stem cells are those cells capable of self-renewal and of differentiation into any blood-cell lineage. By contrast, progenitor cells are committed
More informationTreatment of Multiple Myeloma with Stem Cell Transplantation (SCT)
Treatment of Multiple Myeloma with Stem Cell Transplantation (SCT) Görgün Akpek, MD, MHS Director, SCT and Cellular Therapy Program Banner MD Anderson Cancer Center GAkpek@mdanderson.org MULTIPLE MYELOMA
More informationHematopoietic Stem Cells
Hematopoietic Stem Cells Isolate Culture Verify Differentiate Investigate a brand Hematopoietic Stem Cells Hematopoietic stem cells (HSCs) are multipotent, self-renewing progenitor cells from which all
More informationIssues in production of viral gene transfer vectors. Stefan Kochanek Department of Gene Therapy Ulm University
Issues in production of viral gene transfer vectors Stefan Kochanek Department of Gene Therapy Ulm University Only few positive results in gene therapy so far - many early phase, few late phase clinical
More informationWhere are we with gene therapy?
Where are we with gene therapy? Session 9: Gene Based Therapies Professor Alan Boyd PFPM 7 th February 2018 Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians, UK Topics to be covered Gene
More informationRegulatory Requirements for CRISPR Therapeutics. Bill Lundberg, MD February 2017
Regulatory Requirements for CRISPR Therapeutics Bill Lundberg, MD February 2017 Forward Looking Statements This document contains forward-looking statements within the meaning of the safe harbor provisions
More informationCatalog # Product Size PRIME-XV Hematopoietic Cell Basal XSFM 500 ml (liquid) Additional package sizes are available at request
PRIME-XV HEMATOPOIETIC CELL BASAL XSFM PRIME-XV Hematopoietic Cell Basal XSFM is an optimized xeno- and serum free media recommended for use in the expansion of human hematopoietic cells, including hematopoietic
More informationHCT/P Regulation vs 361 Products
HCT/P Regulation - 351 vs 361 Products Presented by: Paul Gadiock February 15, 2017 Arent Fox LLP Washington, DC New York, NY Los Angeles, CA San Francisco, CA 1 Presentation Overview Introduction Public
More informationQuality Control in Flow. Dr David Westerman Head of Haematopathology Peter MacCallum Cancer Centre
Quality Control in Flow Dr David Westerman Head of Haematopathology Peter MacCallum Cancer Centre Aims Quality Assurance Quality Control Literature In house competencies SHOT DATA 1996-2009 Ref: SHOT Annual
More informationResearch Xchange Forum 2018
Research Xchange Forum 2018 Insights Translation Solutions Trends and Challenges in Regenerative Medicine & Cell Therapy March 20 21, 2018 Sartorius Goettingen, Germany What to expect Learn about the latest
More informationOverview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations. Audrey Chang, PhD, Senior Director Development Services
Overview of Biologics Testing and Evaluation: Regulatory Requirements and Expectations Audrey Chang, PhD, Senior Director Development Services Definition of Biologics: PHS Act, section 351 Virus, therapeutic
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 19.6.2002 COM(2002) 319 final 2002/0128(COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on setting standards of quality and
More informationSeveral cellular therapies are
B i op r o c e s s Technical Manufacturing Patient-Specific Cell Therapy Products An Overview and Case Study of Tissue Repair Cell Technology Brian Hampson, Jon Rowley, and Naia Venturi Several cellular
More informationMedical Issues in a Clinical Cellular Therapy Laboratory. Kala Mohandas, MD Director, Cellular Therapy Lab Montefiore Medical Center Bronx, NY
Medical Issues in a Clinical Cellular Therapy Laboratory Kala Mohandas, MD Director, Cellular Therapy Lab Montefiore Medical Center Bronx, NY Objectives Major, Minor and Bidirectional ABO Incompatibility
More informationThe challenges of potency assay development for cell-based medicinal products in Europe
Focus Advanced therapies 5 The challenges of potency assay development for cell-based medicinal products in Europe Authors Valerie Pimpaneau, Senior Director, Voisin Consulting Life Sciences; François
More informationPrioritization of Neoantigens without Predictions: Comprehensive T cell Screening using ATLAS
Prioritization of Neoantigens without Predictions: Comprehensive T cell Screening using ATLAS Jessica Baker Flechtner, PhD CSO, Genocea Biosciences 15 November 2016 1 Safe Harbor Statement This presentation
More informationGuide to Clonetics and Poietics Cell Types
Guide to Clonetics and Poietics Cell Types Clonetics and Poietics Cell Types - Sorted By Tissue Source Cryopreserved Human Cells Adipose Subcutaneous Preadipocytes PT-5001 PGM -2 PT-8002 Visceral Preadipocytes
More informationImmunotherapy in Hemato-Oncology
ESMO Preceptorship Programme Immuno-Oncology From tumor immunology to clinical application 2-3 November 2016 Zurich - CH Immunotherapy in Hemato-Oncology Markus G. Manz Klinikdirektor Hämatologie USZ Leiter
More informationBill Kabat and Carmen Irizarry of the ACTG/IMPAACT Lab Tech Committee. Network Name, Title Signature Date
Title: Dried PBMC Pellet Processing Standard Operating Procedure (LDMS specimen code = BLD/EDTA or ACD/PEL) Origination Date: 01 Jun 2004 Total Pages: 6 Effective Date: 29 Nov 2012 SOP Number LTC-SOP-59
More informationJanice Soreth, M.D. Deputy Director FDA Europe Office Liaison to EMA. Making Gene and Cell Therapy a Reality July 10-11, 2012 Dublin
Janice Soreth, M.D. Deputy Director FDA Europe Office Liaison to EMA Making Gene and Cell Therapy a Reality July 10-11, 2012 Dublin Acknowledgments Celia Witten, Ph.D., M.D. Director Office of Cellular,
More informationCellometer Vision CBA
Features of the Vision CBA Image Cytometry System All-in-One System Basic cell counting, primary cell viability, and cellbased assays. See for Yourself Why the Top Ten Pharmaceutical Companies Trust Cellometer
More informationGREAT STRIDES IN SCIENCE WHAT ABOUT ACCESS? Marlene E. Haffner, MD, MPH 2nd IRDiRC Conference Shenzhen, China November 8, 2014
GREAT STRIDES IN SCIENCE WHAT ABOUT ACCESS? Marlene E. Haffner, MD, MPH 2nd IRDiRC Conference Shenzhen, China November 8, 2014 1982 WHAT HAS HAPPENED SINCE IN TECHNOLOGY ASSESSMENT AND. US Orphan Drug
More informationINDUSTRY PERSPECTIVE: REGULATORY ASPECTS OF DEVELOPING PERSONALIZED CANCER VACCINES
INDUSTRY PERSPECTIVE: REGULATORY ASPECTS OF DEVELOPING PERSONALIZED CANCER VACCINES Kathleen Francissen, Ph.D. Senior Director, CMC Regulatory Genentech, A Member of the Roche Group ISPE Biopharmaceutical
More information2. The Principles of Dynabeads
2. The Principles of What Are? 9 How Are Used? 9 Different Types of 10 Surface Activated, Primary and Secondary-Coated 10 Small and Large 10 Different Separation Strategies 11 Positive Isolation: Binding
More informationEfficacy of CD 25 blockade as targeted adjuvant therapy in the prevention of GVHD in pediatric stem cell transplant recipients
Aus der Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin an der Martin-Luther-Universität Halle-Wittenberg Direktor: Prof. Dr. med. St. Burdach Efficacy of CD 25 blockade as targeted adjuvant
More informationBiotechnology Projects. What do NTHRYS Provide under these Project Works?
Biotechnology Projects NTHRYS provides Biotechnology Projects for interested candidates at its Hyderabad facility, Telangana. Please refer below for more details including Fee strctures, Eligibility, Protocols
More informationAUTOIMMUNE HEPATITIS EXPERIMENTAL MODEL BASED ON. Sainte-Justine University Hospital, Montreal (Quebec), H3T 1C5, Canada; 3 Departments
1 2 AUTOIMMUNE HEPATITIS EXPERIMENTAL MODEL BASED ON ADENOVIRAL INFECTIONS 3 4 Authors: Pascal Lapierre 1, Kathie Béland 2 and Fernando Alvarez 2,3,4 5 6 7 Affiliations: 1 Immunovirology Laboratory, INRS-Institut
More informationDeveloping assays to address identity, potency, purity and safety: cell characterization in cell therapy process development
For reprint orders, please contact: reprints@futuremedicine.com Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development A major challenge
More informationApplication of Quality Risk Management Tools for Cell Therapy Manufacturing
Application of Quality Risk Management Tools for Cell Therapy Manufacturing 17 th ISCT Annual Meeting May 20, 2011 Jean Stanton Associate Director, Product Quality Management Janssen Supply Chain Conflict/Disclaimer
More informationDirect Cell Counting Assays for Immuno Therapy
Direct Cell Counting Assays for Immuno Therapy Cytotoxicity assays play a central role in studying the function of immune effector cells such as cytolytic T lymphocytes (CTL) and natural killer (NK) cells.
More informationBlood Product Utilization
Who gets what & when Why not to give blood? Volume Expander For specific number (except as related to procedures) To patients with religious objections to blood transfusions Blood given only when necessary
More informationPlatelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD
Platelet Refractoriness: The Basics Martin H. Bluth, MD, PhD Complete Toxicology Laboratories, LLC Objectives Define platelet refractoriness and associated conditions that may cause platelet refractoriness.
More informationImmuno-Oncology Opportunities and Challenges In Moving Toward a Cure for Multiple Myeloma
Immuno-Oncology Opportunities and Challenges In Moving Toward a Cure for Multiple Myeloma Stanley R. Frankel, MD, FACP Corporate Vice President, Clinical R & D Head, Immuno-Oncology Celgene Cancer Progress
More informationFDA Perspectives On Viral & Vector Shedding Studies. Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007
FDA Perspectives On Viral & Vector Shedding Studies Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007 Overview Define shedding studies Outline basis for need of
More informationGMO Technology Conference
GMO Technology Conference The regulation of Clinical Trials on humans involving therapies containing or consisting of genetically modified organisms The Printworks, Dublin Castle 10 th & 11 th October
More informationSupplemental Information Inventory
Cell Stem Cell, Volume 6 Supplemental Information Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1 Grant A. Challen, Nathan C. Boles, Stuart M. Chambers, and Margaret A.
More informationBlue Marble University Biology Course Handbook
Blue Marble University Biology Course Handbook A Summary of Course Descriptions Courses and Content Subject to Change Without Notice BlueMarbleUniversity.com Info@bluemarbleuniversity.com Stem Cell Biology
More informationBringing the EuroFlow Concept
Bringing the EuroFlow Concept Cytognos - EuroFlow Supporting Company Company Overview Cytognos provides through worldwide distribution a broad range of reagents and software for flow cytometry applications
More informationEXAMPLE OF VENDOR QUALIFICATION FOR IMMUNE EFFECTOR CELL PRODUCT MANUFACTURER
EXAMPLE OF VENDOR QUALIFICATION FOR IMMUNE EFFECTOR CELL PRODUCT MANUFACTURER Disclaimer: This example is just one potential example of a vendor qualification form to verify the adequacy of the internal
More informationParesh Vishwasrao. M.Sc. Zoology, Molecular Biology, University of Pune, MH, India
Paresh Vishwasrao 1 Phone #: (201) 491 3741 Email: vishwasrao.paresh@gmail.com Webpage: http://developinginsights.org Education: Ph.D. Translation Immunology and Immunotherapy, 2011-2017 Academic Med Center
More informationGene therapy in rare anemias
Gene therapy in rare anemias Jose Carlos Segovia Differentiation and Cytometry Unit. Hematopoietic Innovative Therapies Division CIEMAT-CIBER / IIS-FJD Madrid - Spain 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS
More informationRegulatory Implications for Global Manufacturing Development of Regenerative Medicines
Regulatory Implications for Global Manufacturing Development of Regenerative Medicines Katherine Tsokas, JD June 2017 Global Regulatory Affairs Janssen Research & Development, LLC Jessica Riley, Shells
More informationImmunotherapy in myeloma
Immunotherapy in myeloma This Horizons Infosheet contains information on immunotherapy, a type of treatment being investigated in myeloma. The Horizons Infosheet series provides information relating to
More informationPERFECT-COUNT MICROSPHERES
PERFECT-COUNT MICROSPHERES Perfect-Count Microspheres-Product code PCB-100 for 100 tests Introduction In recent years, the determination of absolute cell counts has been shown to be relevant in different
More informationAdult Stem Cells by David A. Prentice, Ph.D.
Adult Stem Cells by David A. Prentice, Ph.D. Within just a few years, the possibility that the human body contains cells that can repair and regenerate damaged and diseased tissue has gone from an unlikely
More informationCells (DPSCs) that show high selfrenewal and peripheral blood have been compatible donor, who was a
NEWS 03 March 2008 www.biohellenika.gr Biohellenika SA is the only Accredited by ÅÓÕÄ Stem Cell Cryopreservation Company Clinical applications of umbilical cord blood stem cells for nonmalignant diseases
More informationQuality Management. Carlos Bachier, MD
Quality Management Carlos Bachier, MD Goals of Quality Management Ensure credibility of outcomes Improve patient safety and quality of processes Significantly reduce errors Quality Medical and Laboratory
More informationUS FDA: CMC Issues for INDs
ISBTC Global Regulatory Summit October 29, 2008 US FDA: CMC Issues for INDs Keith Wonnacott, Ph.D. keith.wonnacott@fda.hhs.gov US Food and Drug Administration Center for Biologics Evaluation and Research
More informationAdipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords
Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords Dr. Vasiliki E Kalodimou, Head of Flow Cytometry-Research and Regenerative Medicine Department, IASO-Maternity
More informationTEPZZ 79 6 B_T EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION
(19) TEPZZ 79 6 B_T (11) EP 2 791 163 B1 (12) EUROPEAN PATENT SPECIFICATION () Date of publication and mention of the grant of the patent: 01.03.17 Bulletin 17/09 (21) Application number: 12870.0 (22)
More informationTechnical Applications Track 2 Safety Testing for Cell Therapy Products: Requirements, Relevance, and New Technologies
ISCT Annual Meeting Rotterdam, The Netherlands 19 May 2011 Technical Applications Track 2 Safety Testing for Cell Therapy Products: Requirements, Relevance, and New Technologies Speakers Scott Burger (USA)
More informationNo-wash, no-lyse detection of phagocytic cells via a phrodo BioParticles functional assay in human whole blood on the
APPLICATION NOTE Attune NxT Flow Cytometer No-wash, no-lyse detection of phagocytic cells via a phrodo BioParticles functional assay in human whole blood on the Attune NxT Flow Cytometer Introduction Analysis
More information